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Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is
caused by recessive mutations in the AIRE gene. The hallmark of the disease is
the production of highly neutralizing autoantibodies against type I interferons and IL-
22. Considering the importance of IL-22 in maintaining mucosal barrier integrity and
shaping its microbial community, we sought to study potential changes in the oral
cavity in this model of human IL-22 paucity. We found that besides known Th22
cell deficiency, APECED patients have significantly fewer circulating MAIT cells with
potential IL-22 secreting capacity. Saliva samples from APECED patients revealed local
inflammation, the presence of autoantibodies against IFN-α and IL-22, and alterations
in the oral microbiota. Moreover, gene expression data of buccal biopsy samples
suggested impaired antimicrobial response and cell proliferation, both of which are
processes regulated by IL-22. Our data complement the knowledge gained from mouse
models and support the concept of IL-22 being a critical homeostatic cytokine in human
mucosal sites.
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INTRODUCTION
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome is a rare recessive
monogenic disorder (1). The responsible gene, AIRE, is expressed in the thymic medullary epithelial
cells to support the negative selection of thymocytes that are potentially reactive to peripheral
tissue-specific antigens (2–5). Nevertheless, among the autoimmune manifestations, the impaired
clearance of Candida infection from the mucosal surfaces stands out as the most common and,
usually, the first manifestation of the disease (6, 7). It is well established that CMC correlates
with circulating autoantibodies against Th17 related cytokines IL-22 and IL-17F (8–10), and that
the secretion of the respective cytokines is severely impaired in the circulating and skin-residing
Abbreviations: AHR, aryl hydrocarbon receptor; AIRE, autoimmune regulator; AMP, antimicrobial peptide; APECED,
autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; ASV, amplicon sequence variant; CMC, chronic
mucocutaneous candidiasis; IPA, ingenuity pathway analysis; LIPS, luciferase based immunoprecipitation system; MAIT,
mucosal associated invariant T; NKT, natural killer T; TFIIH, transcription factor IIH.
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CD4+ T cells (9, 11). The potential pathogenicity of the IL-22-
neutralizing autoantibodies, isolated from APECED patients, has
been confirmed in a mouse model of oropharyngeal candidiasis,
where the antibody treatment caused delayed clearance of the
yeast from the oral cavity (12).
IL-22 is essential for mucosal barrier function. It can
protect from intestinal injury by supporting epithelial cell
proliferation and wound healing, enhancing tight junctions,
upregulating antimicrobial peptide, and mucus production (13–
16). Moreover, IL-22 was recently shown to protect intestinal
stem cells against genotoxic stress and thus against colon cancer
(17). IL-22 is also capable of shaping gut microbiota (18). In
contrast, the excessive production of IL-22 is associated with
tissue inflammation in several immune-mediated inflammatory
diseases, such as psoriasis, celiac disease, and rheumatoid arthritis
(19–23).
While the target cells of IL-22 action are mostly epithelial
cells, the best producers of IL-22 are various lymphoid cells:
Th17 (24), Th22 (25), type 3 innate lymphoid cells (26), and
several unconventional T cells, such as γδ T (27), MAIT (28,
29), NKT (30), and invariant NKT cells (31). Unconventional
T cells are crucial for the protection and homeostasis of the
epithelial surfaces due to their immediate response to harmful
agents. However, they are less studied in APECED patients than
are conventional T cells.
Most of the knowledge about the functions of IL-22 have been
derived from mouse and in vitro experiments. We reasoned that
APECED can be viewed as a model disease that enables to study
the consequences of IL-22 insufficiency in human oral mucosa.
The shortage of IL-22 in APECED is thought to be associated
with CMC, but considering the importance of this cytokine for
epithelial cell homeostasis in the digestive tract, we hypothesized
that it should lead to various other important consequences for
epithelial homeostasis.
MATERIALS AND METHODS
Subjects
We studied 13 patients with APECED (9 males, 4 females)
from Slovenia and Estonia and 16 control subjects, who were
age and gender adjusted for the study, and recruited at the
same time with the patients. Use of human material was
approved by local ethics committees (Slovenia: National Medical
Ethics Committee number 22/09/09 and 28/02/13; Estonia:
Research Ethics Committee of the University of Tartu, 235/M-
23). Informed consent was obtained from all participants or
parents of participating children. Patient details are given in
Supplementary Table 1.
Material
Peripheral blood was drawn into heparinized vacutainers,
separated into plasma and peripheral blood mononuclear cells
and stored at −20◦C or liquid nitrogen, respectively, until
usage. The saliva samples were provided using the passive-
drool method, in which study participants allowed saliva to
pool in the mouth and then drool it into a tube. Donors
did not eat or drink for 30 min before sample collection.
Samples were stored at −80◦C. Buccal biopsies were taken with
surgical scalpel under aseptic conditions after local anesthesia.
A core from the buccal mucosa of either the left or right cheek
was obtained, rinsed in sterile PBS and snap frozen. None of
the studied patients or controls received immunosuppressive
treatment, reported sicca symptoms nor had difficulties in
saliva collection.
Flow Cytometry
Surface marker expression on PBMCs was assessed by flow
cytometry in 8 patients and 8 age matched control subjects.
Cells were stained in flow cytometry buffer (PBS (pH 7.2),
2 mM EDTA, 0.5% BSA) for 20 min at room temperature
in dark with antibodies listed in Supplementary Table 2.
After staining, cells were analyzed using LSRFortessa flow
cytometer (BD Biosciences) and FCS Express 5 Flow (De Novo
Software). The optical detector configuration can be found in
Supplementary Table 3. The gating strategy is depicted in
Supplementary Figure 1.
Autoantibodies From Plasma and Saliva
With LIPS
Luciferase based immunoprecipitation system assay was
conducted on saliva samples (10 APECED patients and 10
controls) and on plasma samples (13 APECED patients
and 7 controls). LIPS assay was performed as previously
described (32). Briefly, IFN-α, IL-17A, IL-17F, and IL-22
coding sequences were cloned into modified pPK-CMV-F4
fusion vector (PromoCell GmbH, Germany) where Firefly
luciferase was substituted with NanoLuc luciferase (Promega,
United States). Cloned constructs were transfected into HEK293
cells and secreted luciferase fusion proteins were collected
with culture medium after 48 h. IgG from plasma and saliva
samples was captured onto Protein G Agarose beads (Exalpha
Biologicals, United States) at room temperature for 1 h in
96-well microfilter plate (Merck Millipore, Germany). Next,
1 × 106 luminescence units (LU) of antigen was added per well.
After 1 h of incubation the unbound antigen was washed away
with vacuum system and Nano-Glo R© Luciferase Assay Reagent
(Promega, United States) was added. Luminescence intensity was
measured by VICTOR X Multilabel Plate Reader (PerkinElmer
Life Sciences, United States). The results were expressed as
luminescence units (LU) representing the fold over the mean of
the heathy control samples.
Cytokines From Saliva and Plasma
Cytokine quantification was conducted on saliva samples (10
Slovenian patients and 8 controls, with exception for TNF-α,
IL-2, IL-1β, IL-5, IL-6, IL-10, GM-CSF, and IFN-γ which were
measured with 6 patient samples and 5-6 control samples) and on
plasma samples (8 patients and 9 controls, with the exception of
TNF-α, IL-2, IL-1β, IL-5, IL-6, IL-10, GM-CSF, and IFN-γ, which
were measured from 7 patients and 8 controls). Cytokine levels in
saliva samples and EDTA-treated plasma samples were measured
by the xMAP Technology on Luminex 200 (Luminex Corp.,
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Austin, TX, United States) with Human Magnetic Luminex
Performance Assay Kits (R&D Systems, Minneapolis, MN,
United States) (Supplementary Table 4). The cytokine levels
were analyzed in accordance with the manufacturer’s protocol.
The cytokines studied are listed in Supplementary Table 5
including their lower limits of detection. The values of IL-1α
in plasma samples and IL-2, IL-5, IL-17A, IL-17F, and IL-22
in both sample types fell below the detection limits in the
majority of tested samples and therefore were excluded from
further analysis.
Gene Expression From Buccal Biopsy
Buccal biopsy samples were derived from 4 patients and 4
age-matched healthy controls. However, after RNA isolation,
2 control samples did not pass the RNA quality control, and
therefore, the gene expression analysis was conducted on 4
APECED patient and 2 control buccal biopsy samples. The
biopsy specimens were homogenized in TRIzol (Invitrogen)
and RNA in the aqueous phase was extracted with the
miRNeasy Mini Kit combined with the RNase-free DNase I
treatment (both from Qiagen). The concentration and quality
of the RNA were assessed with an Agilent RNA 6000 Nano
Kit on Agilent 2100 Bioanalyzer (Agilent Technologies, CA,
United States). Next, cRNA was prepared from 300 ng of
total RNA using an Illumina TotalPrep RNA Amplification
Kit (Ambion Inc., TX, United States) according to the
manufacturer’s protocol and a genome-wide gene expression
analysis was carried out using HumanHT-12 v4 Expression
BeadChip (Illumina Inc., CA, United States) and the signals
were scanned using a Beadscan (Illumina Inc.). Array data
were analyzed using GenomeStudio software (Illumina, San
Diego, CA, United States). Rank invariant normalization was
applied. Genes with the FDR adjusted p-value < 0.05 and a
fold change > 1.5 were considered to be differentially expressed.
A positive diffScore represents upregulation, while a negative
diffScore represents downregulation. The p-value for an observed
expression difference between two analyzed groups of samples
is <0.05 for genes with diffScores of lower than −13 and
higher than +13 (p-value < 0.01 is −20 > diffScore > 20;
p-value < 0.001 is−33 > diffScore > 33). The data with negative
average signal value was excluded from the list. Annotation
analysis was implemented with gprofiler software (33) and
IPA software (QIAGEN Inc)1. Analysis data set included the
upregulated and downregulated gene list with expression fold
change. The core analysis was carried out on reference set
Ingenuity R© Knowledge Base (Genes only). The settings were
by default including direct and indirect relationships between
genes, 35 genes per network, 25 networks per analysis. Diseases
and functions analysis was conducted, which predicted cellular
processes and biological functions, based on gene expression.
Z-score provides predictions about upstream or downstream
processes. Network analysis generated the scores [p-score = -
log10 (p-value)] according to the fit of the set of supplied
genes and a list of biological functions. Focus Genes were
those from the uploaded list that pass filters and are eligible
1https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/
for generating networks. Only genes with a fold change of
1.5 and p-value ≤ 0.05 were considered. Upstream regulator
analysis in IPA was used to predict the upstream transcriptional
regulators from the dataset based on the literature and compiled
in the Ingenuity Knowledge Base. Upstream regulator analysis
calculated the causal networks. The causal networks scores
were calculated using causal paths only. Two p-values we
calculated: Fishers Exact Test of whether there was a greater
than expected proportion of downstream data set genes than
expected by chance. Network bias corrected p-value was a
measure of how often a more significant result was seen in 10K
iterations of selecting random data sets of genes with similar
relationship number.
Candida Detection From Saliva
DNA from saliva samples and cultured laboratory strain
SC5314 (ATCC, VA, United States) of Candida albicans was
extracted using the DNeasy PowerSoil Kit (QIAGEN) according
to manufacturer’s protocol. Samples were homogenized
with Precellys 24 Homogenizer (Bertin Instruments) with
program 6500 rpm, 2 min’ homogenization and 1-min
break. Real time quantitative PCR was performed using
Applied Biosystems R© ViiATM 7 Real-Time PCR System
with 384-Well Block (Life Technologies) and Maxima SYBR
Green/ROX qPCR Master Mix (Fermentas). A primer pair
of highly conserved Candida rDNA-coding region 28S
was used (forward CGGCGAGTGAAGCGGCTAA, reverse
ATTCCCAAACAACTCGACTC) (34). The concentration
of Candida cells in patient samples was calculated based
on the calibration curve constructed according to the Ct
values of serially diluted C. albicans probes (starting from
2E7 CFU/ml). The normal range of Candida concentration
was calculated based on healthy control values: mean + 3
standard deviations.
Sequencing, Processing and Statistical
Analysis of Bacterial 16S rDNA
Sequences
DNA from saliva samples was manually extracted using
the MolYsisTM Complete 5 Kit according to manufacturer’s
protocol with 20 µl elution of DNA in water. The bacterial
16S rDNA variable region V1-V2 amplicon libraries were
prepared using the 27F-338R primer combination in a dual
indexing approach. Sequencing was performed on an Illumina
MiSeq device using 2 × 300 cycles and MiSeq Reagent Kit
v3 (35). The Dataset included 6 Slovenian patient and 6
control samples. Raw-Data were processed using the DADA2
workflow2 (v1.10) and subsequently analyzed in R using the
vegan and phyloseq packages. Taxonomic annotation was
performed using a Bayesian classifier and RDP training set
16. For each sample, 20k sequences were randomly sampled
for a normalized read count. Analysis was performed on
ASV, species and genus level. For differentially abundant
taxonomic group all tests were performed using Wilcoxon
2https://benjjneb.github.io/dada2/
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FIGURE 1 | Comparison of circulating lymphocyte subpopulations. Surface marker expression on PBMCs was assessed by flow cytometry in 8 APECED patients
and 8 age-matched controls. The percentage of Vδ1+ and Vδ2+ γδ T cells, iNKT and MAIT cells from total T cell pool was compared between patient and control
sample groups. In the violin plot the width of distribution of points is proportionate to the number of points at the value of the sample. Black discontinuous line
represents median and colored discontinuous line represents quartiles. Statistical significance was assessed with t-test using R statistical software (*p < 0.05). The
outliers for different cell types did not overlap, with the exception of the APECED patient who had the highest proportion of both γδ T cell subtypes.
rank sum test using only taxa with median abundance > 100
sequence counts (0.5% rel. abundance) and prevalence > 0.3
(present in at least 4 samples). Alpha diversity (within sample
diversity) was analyzed with Wilcoxon rank sum tests. Diversity
indices used were as follows: Observed – Observed taxa
with abundance > 0, Shannon – Shannon Diversity Index,
Chao1 – Chao1 Estimator to estimate observed and unobserved
species count. Differences in beta diversity (Whole Community
Composition/inter-sample diversity), were assessed using Bray-
Curtis similarity and permutational multivariate analysis of
variance as implemented in the adonis() function of the
vegan package for R. The sequences have been deposited in
the NCBI Sequence Read Archive Database3 under accession
number PRJNA601650.
Statistical Analysis
Statistical analysis was performed using the R statistical software4
and GraphPad Software (San Diego, CA, United States).
RESULTS
APECED Patients Have Decreased MAIT
Cell Proportions in Their Circulation
With regard to the severe deficiency of Th22 cells in the
blood circulation and skin of the APECED patients (9, 11),
we enquired if the proportions of unconventional T cells,
that are known for their IL-22 production capability, are
also impaired in the patients. We used flow cytometry to
enumerate these cells (Figure 1) (gating strategy displayed in
3https://www.ncbi.nlm.nih.gov/sra
4https://www.r-project.org/
Supplementary Figure 1). Vδ1+ and Vδ2+ γδ T cell proportions
were not significantly altered, in accordance with previous studies
(36), neither did the iNKT cell numbers differ between patient
and control samples. Nevertheless, the percentages of MAIT cells
(Vα7.2 TCR+ and CD161+) among T cells were lower in patients
than in healthy controls (p < 0.05).
Saliva From APECED Patients Contain
Cytokine Autoantibodies and Reflect
Inflammation
As IL-22 and MAIT cells are both important players in mucosal
homeostasis and protection, we analyzed saliva samples from
patients and controls to find signs of perturbations on oral
mucosa. First, we tested the saliva and corresponding plasma
samples for the presence of cytokine autoantibodies (Figure 2).
Importantly, anti-IFN-α and anti-IL-22 autoantibodies were
present in saliva from all the 10 APECED patients. Salivary
anti-IL17A and anti-IL17F autoantibodies were detectable at
very low levels in a fraction of the patients who tested positive
for corresponding circulating autoantibodies. In addition, we
detected LCN1 autoantibodies from the plasma of 3 of
13 APECED patients. We also tested for different anti-
S100A subtypes (S100A7A, S100A7, S100A8, S100A9) in the
plasma, but there was no difference between patient and
control groups (Supplementary Figure 2). Collectively, these
findings suggest that the local presence of IFN-α and IL-22
autoantibodies can aggravate the insufficiency of these cytokines
on mucosal surfaces.
Next, we compared the salivary concentration of various
cytokines in APECED patients with those in healthy
controls (Supplementary Table 5). IL-22, IL-17A, and IL-
17F levels remained undetectable in majority of the samples.
However, proinflammatory cytokines TNF-α, GM-CSF, and
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FIGURE 2 | Autoantibodies from saliva and plasma. LIPS assay was conducted on (A) saliva samples (10 patients and 10 controls) and on (B) plasma samples (13
patients and 7 controls). The results were expressed as luminescence units (LU) representing the fold over the mean of the heathy control samples. The horizontal
blue line represents the geometric mean of the LU of the control sample group (saliva n = 10, plasma n = 7). The transparent blue area shows normal range e.g., ±3
standard deviations of the geometric mean.
IFN-γ were all significantly increased compared to control
group (Figure 3A). This increase was reflective of the
local inflammation as the difference was not recapitulated
in the plasma samples (Figure 3B). From tested plasma
cytokines, only CXCL10 was significantly increased in
patients compared with that in controls, confirming an earlier
report (37).
Furthermore, correlation analysis was conducted to compare
the Candida concentrations (CFU/ml) with significantly
increased cytokine levels and autoantibody levels from patient
saliva samples (Supplementary Figure 3). There was no
correlation between CFU values and proinflammatory cytokine
concentrations. The only significant correlation was between
salivary anti-IL-17A levels and Candida CFU, but this was
caused by the one outlier – the patient with the highest
Candida CFU value had the highest IL-17A antibody level
(Supplementary Figure 4).
Buccal Biopsy Transcriptomes Reveal
Alterations in APECED Oral Mucosa
The gene expression analysis was conducted on 4 APECED
patient and 2 control buccal biopsy samples. Differentially
regulated genes were identified based on gene expression
diffScore (Supplementary Table 6). Seventeen significantly
up-regulated and 91 significantly down-regulated genes were
identified. Among the upregulated genes, several transcripts were
associated with tumorigenesis (SNHG7, SHIP2, FANCG, and
DDR2). In contrast, several AMP genes (DEFB103B, DEFB103A,
and S100A12) and genes important for epithelial barrier
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FIGURE 3 | Cytokine quantification. Cytokine measurement assay was
conducted on (A) saliva samples (6 patients and 5–6 controls) and on (B)
plasma samples (7 patients and 8–9 controls). Concentration of cytokines
from the saliva and from the plasma of patient and control samples groups. In
the violin plot the width of distribution of points is proportionate to the number
of points at the value of the sample. Black discontinuous line represents
median and colored discontinuous line represents quartiles. Statistical
significance was assessed with the t-test using the Graphpad Prism software
(*p < 0.05, **p < 0.01, and ***p < 0.005).
function (SPRR2C, SPRR2B, and TGM5) were downregulated.
The significantly downregulated genes were further analyzed
with gProfiler database. Mitotic cell cycle was identified as an
associated biological process. In addition, the gene lists together
with fold changes were analyzed by IPA. We carried out a
diseases and functions analysis, which predicted the biological
processes (cellular processes, biological functions, etc.) affected
by the expression of a specific gene. The main terms that emerged
were connected with cell cycle and mitosis (Supplementary
Table 7), the cell cycle process was predicted to be inhibited in
patients (p-value 3.5E-08, activation z-score -2.256). Next, we
carried out a network analysis, which predicts gene interaction
map (Supplementary Table 8). We focused on the network
with the highest score, which consisted of 23 focus molecules
and 12 interconnecting molecules (“non-focused” proteins that
were not present in our list). The main network included
the following biological terms: antimicrobial response, cellular
function and maintenance, and inflammatory response (Figure 4
and Supplementary Figure 5).
Finally, we conducted an upstream regulator analysis, which
predicts the activity state of regulators by correlating literature
reported effects with observed gene expression. Participating
regulators are molecules through which the upstream regulator
molecule controls the expression of target molecules in dataset.
The top two master regulators, identified in the dataset,
were TFIIH and AHR, based on the highest p-value of
overlap (Supplementary Table 9 and Supplementary Figure 6).
Transcription factor IIH (TFIIH) is an important protein
complex with many biological roles, ranging from DNA repair
to transcription to cell cycle regulation (38). AHR is highly
expressed by Th17 cells, and activation of AHR results in
expansion of Th17 cells and enhanced production of Th17
cytokines, particularly IL-22 (15, 39, 40).
Taken together, the gene expression array results hint that
IL-22-controlled pathways may be downregulated in the buccal
biopsy samples of APECED patients.
Salivary Microbiota Analysis Is
Consistent With Dysbiosis in APECED
Oral Cavity
Salivary microbiota was analyzed in 6 APECED patients and 6
age-matched healthy controls. The microbial communities were
significantly different in APECED patients in comparison to
healthy controls on the whole community (beta-diversity) level
(Figure 5). All differences were significant in permutational
ANOVA (ASV: R2 = 14.6%, p = 0.017, species: R2 = 20.2%,
p = 0.036, genus: R2 = 23.5%, p = 0.021). Interestingly,
the 2 patients with elevated Candida levels in their saliva
samples (Supplementary Table 1 and Supplementary Figure 3),
clustered together at the genus and species level (Figure 5).
Next, we analyzed the taxonomic groups. The most abundant
genus in both, patients and controls, was Streptococcus
(Figure 6). Significantly higher abundance of Fusobacterium
(p < 0.05) was revealed in APECED patients, and a relatively
rare genus, Lachnoanaerobaculum, was more abundant in
heathy individuals. At the species and ASV level, we noted
significantly lower abundance of Streptococcus salivarius
(p < 0.05) in APECED patient samples (Figure 7 and
Supplementary Figure 7).
For alpha-diversity analysis, which estimates bacterial
diversity within a sample (Figure 8), three different indices were
used to estimate counts of observed and unobserved species:
observed taxa with abundance over zero, Shannon Diversity
Index, and Chao 1 Estimator. Interestingly, significantly
increased Shannon diversity was found at the species (p < 0.05)
and ASV (p < 0.01) levels in patient samples. Other alpha-
diversity indices showed similar tendencies, but the differences
were not significant in this small dataset.
Taken together, the results of the microbial 16S sequencing
analysis indicated alterations in oral microbiota of APECED
patients and increased alpha-diversity.
DISCUSSION
Since its discovery almost 20 years ago, IL-22 has gained
considerable attention as an essential homeostatic cytokine on
epithelial surfaces. IL-22, belonging to Th17 family of cytokines,
Frontiers in Immunology | www.frontiersin.org 6 May 2020 | Volume 11 | Article 838
fimmu-11-00838 May 7, 2020 Time: 16:51 # 7
Kaleviste et al. Alterations in APECED Oral Mucosa
FIGURE 4 | Ingenuity Pathway Analysis (IPA) network diagram of differentially expressed genes in patient vs. control buccal biopsies. The gene expression analysis
was conducted on 4 APECED patient and 2 control buccal biopsy samples. Differentially regulated genes were analyzed by IPA. Network analysis with the highest
score consisted of 23 focus molecules and 12 interconnecting molecules. Network, which had the highest score (score 51), was categorized by IPA function:
“antimicrobial response, cellular function and maintenance, inflammatory response.” Two genes were considered to be connected if there was a path in the network
between them. The intensity of the gene color indicates the degree of upregulation (red) or downregulation (green) of a given gene. The legend of figure shapes and
relationships can be found in Supplementary Figure 5.
has similar and even synergistic effects with IL-17A, but it
also exerts a plethora of unique effects to secure the barrier
function of epithelium (13–16). In this study, we focused
on a distinctive feature of APECED patients, namely, highly
neutralizing autoantibodies against IL-22 and IFN-α. Previous
studies have substantiated that due to neutralization of the low
physiologic levels of IFN-α, blood cells of APECED patients
have reduced levels of IFN-induced gene expression compared
with that of healthy controls (37). Moreover, CMC in APECED
patients is associated with the presence of circulating anti-IL-22
and IL-17F (11, 32, 41) and with the incapability of circulating
and skin CD4+ T cells to secrete IL-22 after their stimulation
in vitro. In addition, impaired mucosal barrier function has
been suspected in APECED patients due to increased levels of
antibodies to commensals (42). In this study, we focused on the
events occurring in the human oral mucosa.
The cause for the almost complete absence of IL-22
production by circulating and skin CD4+ T cells in APECED
patients is still not known. Furthermore, the role of other
lymphoid cells in Th17-related cytokine secreting capacity is not
yet clear in this disease. However, there is a previous report
suggesting that IL-17A secreting γδ T cells are impaired in
APECED (43). According to current study, the percentages of
Vδ1+ and Vδ2+ γδ T cells did not differ between patients and
controls. The association of iNKT cells with AIRE-deficiency
has remained controversial (10, 44, 45). Our study revealed
no significant difference between patient and control samples
for this cell type. However, we found significantly decreased
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FIGURE 5 | Beta-diversity of the salivary microbiota. Microbiota from salivary samples were analyzed in 6 APECED patients and 6 age-matched healthy controls.
Multidimensional scaling based on Bray-Curtis distances was applied with first and second coordinates depicted for genus, species and ASV levels. Each point
represents the microbiome of one individual. APECED – orange dots, control individuals – blue squares. Crosses represent centroids per group. Black box – patients
with high Candida concentration of saliva samples compared to the normal range of Candida concentration (healthy control values: mean + 3 standard deviations).
proportions of circulating MAIT cells in APECED patients.
MAIT cells are reportedly present in oral mucosa and are capable
of secreting Th17 cytokines (46). Considering this, it is possible
that the paucity of MAIT cells contributes to the shortage of
IL-22 in mucosal surfaces. The deficiency of MAIT cells in
patients can be related to the presence of highly neutralizing
autoantibodies against type I IFNs in APECED because MAIT
cells are activated by type I IFNs, or by aberrations in microbiota
that produce metabolites necessary for MAIT cell development in
the thymus (47).
Although the main producers of IL-22 are distinct cell types
from the lymphoid lineage (48), which are deficient in APECED
patients, dendritic cells, and neutrophils can also contribute to
the circulating or local concentration of IL-22 (49, 50). The
remaining IL-22 from various sources can be neutralized by IL-
22 autoantibodies. Interestingly, we demonstrated autoantibodies
against IL-22 and IFN-α also in patients’ saliva samples, levels
of which varied a lot between patients. In theory, these local
autoantibodies can further aggravate IL-22 shortage although we
do not have formal proof for this. One could also hypothesize that
local neutralization of IFN-α can further impair the recruitment
of cells that could secrete IL-22, as recently reported (51).
As one of the key functions of IL-22 is to induce AMP
secretion from epithelial cells in concert with IL-17A, it is
possible that the secretion of these natural antibiotics is impaired
in APECED patients. However, previous work has not found
decreased beta and alpha defensin concentrations in APECED
saliva samples (52). Our study confirmed abundant, and not
impaired, LCN2 levels in the saliva of APECED patients.
Gene expression analysis of buccal biopsy samples revealed
equally high S100A8 and S100A9 expression in patients and
controls, while some other AMPs (DEFB103B, DEFB103A, and
S100A12) were significantly downregulated in the mucosa of
APECED patients. These results suggest specific but not universal
impairment of AMP production in APECED oral cavity.
Interestingly, autoantibodies against antimicrobial peptides,
DEFA5 (53), LPO (54), BPIFA1 (54), BPIFA2 (54), and LCN1
(55), have been described previously. In addition, we detected
LCN1 autoantibodies in the plasma of three of 13 APECED
patients included in this study, but did not detect autoantibodies
against the S100A family of antimicrobial peptides.
Considering the importance of the tight regulation of IL-
22 levels to enable the symbiosis of the host with commensals
(56), we hypothesized that IL-22 paucity could impact microbial
community in the oral cavity. Indeed, the salivary microbiome
of patients was significantly different from healthy controls
(Figure 7) and showed higher diversity. The dysbiosis in
APECED patients’ oral cavity has been described in an earlier
investigation with some overlaps in differentially abundant
taxonomic units between the two studies, but also with
discrepancies that can arise from various technical, analytical and
biological differences between the two studies (57). Alterations
in the microbiota could also be caused by medications, as
well as Sjögren’s-like syndrome, which is especially frequent
among APECED patients in the United States (10). However,
we think that neither factor had impact on our analysis
as none of the study subjects received immunosuppressive
drugs, and only one patient was on antifungals, all other
medications were only hormone replacements. Moreover,
objective sicca symptoms are rare in European APECED
patients and were reportedly present only in patients over
33 years of age (52). Our study included relatively young
patients (17.7 ± 10.9 years) and none of them reported
dry mouth. Candida infection itself is also a potential
modifier of microbiota. According to the beta-diversity analysis
(Figure 5) the two patients with elevated Candida concentration
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FIGURE 6 | Profiles of the relative abundance per group at genus level in studied groups. Microbiota from salivary samples were analyzed in 6 APECED patients and
6 age-matched healthy controls. Analysis was performed using Wilcoxon rank sum test using only taxa with median abundance > 100 sequence counts (0.5%
relative abundance) and prevalence > 0.3 (present in at least 4 samples) (*p < 0.05).
clustered together at the genus and species level but did
not differ from the other patients in any other studied
parameter. CMC is also a possible inducer of proinflammatory
cytokines that were elevated in the patients’ saliva that in
turn can influence the changes in the microbial communities.
Although we did not see any significant correlation between
Candida CFU values and cytokine concentrations, we cannot
rule it out by our small study group. The cause of the
salivary proinflammatory cytokine increase remains unknown.
The oral cavity was regularly examined by the attended
pediatric endocrinologist and no clinical sings of gingivitis and
periodontitis were appreciated. The autoimmune attack toward
mucosal antigens or preclinical inflammation in the salivary
glands remains an option.
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FIGURE 7 | Profiles of the relative abundance per group at species level in studied groups. Microbiota from salivary samples were analyzed in 6 APECED patients
and 6 age-matched healthy controls. Analysis was performed using Wilcoxon rank sum test using only taxa with median abundance > 100 sequence counts (0.5%
relative abundance) and prevalence > 0.3 (present in at least 4 samples) (*p < 0.05).
In addition to shaping the microbiome composition, IL-
22 is important for epithelial cell proliferation, enhancing
tight junctions and protecting cells from genotoxic stress
(17). Indeed, our gene expression data from buccal biopsy
samples suggested differences in the upstream and downstream
molecular events of the IL-22 pathway. Notably, the upstream
regulator analysis identified AHR, the transcription factor
necessary for IL-22 production, while network analysis
revealed impaired antimicrobial response, cellular function
and maintenance, and inflammatory response. The harmed
epithelial barrier function can be suspected also from the
reduced expression of several genes related with mitotic
cell cycle in patients that can lead to defective wound
healing on epithelial surfaces that can become especially
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FIGURE 8 | Alpha-diversity analysis of salivary microbiota. Within-sample bacterial diversity was analyzed on ASV, genus and species levels in 6 APECED and
respective control samples using three different diversity indices as indicated on the plots (*p < 0.05 and **p < 0.01).
important during inflammatory processes. Importantly,
chronic inflammation due to recalcitrant Candida infection
has been regarded as a susceptibility factor for developing
oral and esophageal squamous cell carcinoma in APECED
patients (58). In line with this, the patient saliva samples
revealed significantly increased levels of proinflammatory
cytokines. As IL-22 was recently shown to protect intestinal
stem cells against genotoxic stress and thus against colon
cancer (17), we suggest that the susceptibility for oral and
esophageal squamous cell carcinoma may result from the
combination of persistent inflammation with the lack of
protective function of IL-22.
Our study has several limitations including a small sample size
and imprecise taxonomic annotation of the 16S amplicons due
to the clade-dependent differences in resolution exhibited by the
amplicon. Moreover, the usual weakness of the human studies is
their descriptive nature and purely indirect reasoning to suggest
some causalities.
CONCLUSION
According to our results, APECED patients are characterized
by alterations in their oral mucosa and increased
diversity of their salivary microbiota, both of which
can be in theory influenced by IL-22 shortage, possibly
aggravated by local action of autoantibodies and paucity of
circulating MAIT cells.
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